3-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-propionic acid, 95.0%, 500mg

2-(2-Bromoethyl)pyridine hydrobromide, 98.0%, 1g

(S)-2-Amino-4-((4-chlorobenzyl)amino)-1-(piperidin-1-yl)butan-1-one dihydrochloride, 98%, 100mg

4,4,5,5-Tetramethyl-2-(4-(naphthalen-2-yl)phenyl)-1,3,2-dioxaborolane, 95.0%, 1g

2,4-Dichloro-8-methoxyquinazoline, 95.0%, 250mg

4-Tetrahydrothiopyranone 1,1-dioxide, 95.0%, 1g

4-Iodo-2-methoxy-1-nitrobenzene, 97%, 1g

Divinylbenzene (m- and p- mixture) (contains Ethylvinylbenzene, Diethylbenzene) (stabilized with TBC)>50.0%(GC)25mL

5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione, 97.0%, 25g

4-(4-Acetyl-phenoxy)-butyric acid, 25g

(1-Methyl-piperidin-4-yl)-acetic acid, 95.0%, 5g

5-Methoxyisoindoline-1,3-dione, 95.0%, 100mg

Manganese(IV) oxide, >90%, precipitated, active, 250 g, glass packaging